openPR Logo
Press release

Animal Biotechnology Market is growing at a CAGR of 9%, North America leads with 45% market share | Key Players:- Boehringer Ingelheim GmbH, Merck & Co.,Inc., Virbac

01-07-2026 08:31 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

animal biotechnology

animal biotechnology

The animal biotechnology market is estimated grow at a CAGR of 9% during the forecast period (2024-2031).

Animal biotechnology refers to using engineering, science, and technology to modify and improve living organisms such as animals. Animal biotechnology can also be further explained as part of biotechnology, where molecular biotechnology techniques are used to genetically manipulate or modify the genome of various animals to improve their suitability for various applications such as pharmaceutical, industrial or agricultural applications. In the same case, animal biotechnology uses multiple methods to diagnose the various diseases in animals, allow the treatment of these diseases through multiple therapeutic options and the development of veterinary drugs, and the preventive care of animals through veterinary vaccines. The vaccination process is a highly effective and crucial tool for preventing animal diseases and promoting animal health and welfare, safe food production and public health.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/animal-biotechnology-market?pratik

Key Industry Developments
✅ December 2025: The NIH and FDA announced initiatives to promote alternatives to traditional animal models in biotech research, accelerating transgenic animal applications for rare disease therapies while emphasizing AI-driven human-relevant models. This shift enhances regulatory flexibility for U.S. firms developing advanced biologics and genetic tools in animal health.

✅ November 2025: Leading U.S. animal biotech firms expanded production of biologics segment products, capturing 34.91% market share amid rising demand for disease-resistant vaccines and diagnostics in livestock and pets. Revenue projections hit USD 8.06 billion for 2025, driven by pet care spending and food security needs.

✅ October 2025: Grand View Research reported U.S. animal biotechnology market growth acceleration, with biologics leading as the fastest-growing segment due to innovations in reproductive genetics and nutrition supplements for sustainable farming.

✅ November 2025: Japanese firms advanced animal biotech collaborations for livestock diagnostics, aligning with Asia Pacific's rapid market expansion fueled by large-scale animal health infrastructure investments in countries like Japan and China. Focus areas included vaccines and genetic breeding for productivity.

✅ September 2025: Japan integrated animal biotechnology into sustainable agriculture protocols, boosting demand for transgenic solutions amid regional food security priorities and veterinary tech adoption. This positioned Asia Pacific as the fastest-growing global market segment.

✅ August 2025: Japanese regulatory bodies supported biotech nutrition products for animals, enhancing disease management in high-density farming operations through partnerships with global players.

Recent M&A Activity:-
✅ Boehringer Ingelheim International GmbH - acquired Saiba Animal Health AG, a specialist in novel therapeutic medicines for pet health, strengthening its portfolio in veterinary biotechnology and expanding access to innovative treatments for animal infectious diseases amid growing demand for advanced biologics.

✅ Zoetis Inc. - acquired Adivo, a German biotechnology firm, gaining state-of-the-art species-specific antibody libraries and technological expertise to accelerate development of cutting-edge veterinary treatments in the animal biotechnology space.

✅ Bioassay GmbH - obtained a GMP Manufacturing License for its veterinary products plant in Germany, enhancing bioanalytical testing solutions and production capacity for animal biotechnology applications like vaccines and diagnostics.

Key Players:-
Boehringer Ingelheim GmbH, Merck & Co.,Inc., Virbac, Elanco, Zoetis, Biogénesis Bagó, Idexx Laboratories, and Heska Corporation.

key Player Highlights:-
◾ Zoetis leads the Animal Biotechnology market with innovative vaccines and diagnostics for livestock and pets, holding approximately 22% market share as of 2025.​

◾ Boehringer Ingelheim excels in biologics and animal health R&D, capturing about 17% market share through global veterinary solutions.

◾ Merck & Co. (Animal Health) drives biotech advancements in therapeutics, securing roughly 13% share with strong livestock portfolios.

◾ Elanco focuses on sustainable biotech for production animals, achieving around 11% market share amid recent expansions.

◾ IDEXX Laboratories dominates diagnostics biotech, with an estimated 9% share via advanced testing platforms.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=animal-biotechnology-market?pratik

Regional Insights:-
North America commands the largest share of the Animal Biotechnology Market, estimated at around 45% in recent assessments, driven by advanced research infrastructure, substantial R&D investments in animal genetics and vaccines, high livestock production, and supportive regulatory frameworks in the US and Canada.

Europe follows as the second-largest region, benefiting from stringent biotech regulations, growing focus on sustainable animal farming in countries like Germany, the UK, and France, and strong demand for veterinary diagnostics and biologics amid steady market expansion.

Asia Pacific ranks third in market share, yet exhibits the fastest growth potential with high CAGRs in nations such as China, India, and Japan, fueled by massive livestock populations, rising meat demand, government investments in agricultural biotech, and expanding veterinary services.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/animal-biotechnology-market?pratik

Market Segmentation-
-By Animal Type: Livestock Leads with 64%
Livestock dominates the Animal Biotechnology Market with 64% market share in 2024, driven by high demand for productivity enhancements in food production animals amid global food security needs.​
Companion animals hold the remaining 36% share, showing faster growth due to rising pet ownership and advanced health solutions for diagnostics and treatments.

-By Product Type: Vaccines at 28%
Vaccines capture over 28% market share in 2024, fueled by rising zoonotic diseases and preventive healthcare needs for livestock and pets.
​Diagnostics tests follow as the fastest-growing segment, with drugs, biologics, and reproductive/genetic products comprising the balance, emphasizing early disease detection.

-By Application: Diagnosis Holds Largest Share
Diagnosis of animal diseases commands the largest share, forming the foundation of veterinary strategies to curb outbreaks and reduce economic losses in livestock.
​Treatment and preventive care segments follow, with drug development and other applications contributing smaller but growing portions amid increasing disease prevalence.

-By End-User: Research Institutions Dominate
Research institutions lead end-use, driving innovations in genetic engineering and biopharmaceuticals essential for market advancements.
​Pharmaceutical companies and agricultural organizations follow, with veterinary hospitals, clinics, and labs gaining from expanded in-house testing and commercialization.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?pratik

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Animal Biotechnology Market is growing at a CAGR of 9%, North America leads with 45% market share | Key Players:- Boehringer Ingelheim GmbH, Merck & Co.,Inc., Virbac here

News-ID: 4338559 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Digital Audio Workstation (DAW) Market Size US$ 10.79 Billion by 2033, CAGR 12.4%, North America Leads with 40% Share
Digital Audio Workstation (DAW) Market Size US$ 10.79 Billion by 2033, CAGR 12.4 …
The global Digital Audio Workstation (DAW) Market reached US$ 3.82 billion in 2024 and is expected to reach US$ 10.79 billion by 2033, growing at a CAGR of 12.4% during the forecast period 2025-2033. Market growth is driven by increasing demand for digital music production, rising adoption of DAWs among independent artists and professional studios, and continuous advancements in audio software technologies. Digital audio workstations are software platforms used for recording,
Decarbonization Market is et to reach US$ 19.47 billion by 2032, with a strong CAGR of 22.82%. | North America leads with 32% market share. Key Players:- Ernst & Young Global Limited, SAP SE, Armstrong International Inc.
Decarbonization Market is et to reach US$ 19.47 billion by 2032, with a strong C …
Global Decarbonization Market reached US$ 3.76 billion in 2024 and is expected to reach US$ 19.47 billion by 2032, growing with a CAGR of 22.82% during the forecast period 2025-2032. The decarbonization market is fueled by strong governmental regulations and international agreements aimed at lowering global emissions. The Paris Agreement, endorsed by almost 200 nations, established lofty objectives to restrict global temperature increase to much below 2°C above pre-industrial levels, with
Geospatial Analytics Market Set for Strong Growth at 12.8% CAGR Through 2031, Led by North America's 38% Market Share | DataM Intelligence
Geospatial Analytics Market Set for Strong Growth at 12.8% CAGR Through 2031, Le …
The Global Geospatial Analytics Market size is projected to reach with a CAGR of 12.8% over the forecast period 2024-2031. Market growth is driven by rising demand for location intelligence in urban planning, agriculture, and disaster management, coupled with widespread adoption of AI, machine learning, and IoT integration in GIS platforms. Advancements in satellite imagery, cloud-based analytics, expanding applications in smart cities and precision farming, and surging investments from governments and
Smart Energy Devices Market Size US$ 83.4 Billion by 2033, CAGR 12.1%, North America Leads with 37% Share, Key Players Include Gree Electric & GE
Smart Energy Devices Market Size US$ 83.4 Billion by 2033, CAGR 12.1%, North Ame …
The global Smart Energy Devices Market reached US$ 28.7 billion in 2024 and is expected to reach US$ 83.4 billion by 2033, growing at a CAGR of 12.1% during the forecast period 2025-2033. Market growth is driven by increasing global focus on energy efficiency, rising adoption of smart grid technologies, and growing deployment of connected and automated energy management systems across residential, commercial, and industrial sectors. Smart energy devices include advanced

All 5 Releases


More Releases for Animal

Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market. Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708 Farm Animals and Companion Animals are the
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report